SARS-CoV-2 Vaccination in Kidney Transplant Recipients: Should We Consider Intradermal Vaccination?

Wijtvliet, Veerle; Wissing, Karl Martin; Abramowicz, Daniel; Ledeganck, Kristien J

Wijtvliet, Veerle; Wissing, Karl Martin; Abramowicz, Daniel; Ledeganck, Kristien J.

Afiliação

Wijtvliet V; Department of Nephrology and Hypertension, Antwerp University Hospital, Edegem, Belgium.
Wissing KM; Department of Nephrology, Universitair Ziekenhuis Brussel, Brussels, Belgium.
Abramowicz D; Department of Nephrology and Hypertension, Antwerp University Hospital, Edegem, Belgium.
Ledeganck KJ; Department of Nephrology and Hypertension, Antwerp University Hospital, Edegem, Belgium.

J Am Soc Nephrol ; 33(4): 869-870, 2022 04.

Article em En | MEDLINE | ID: mdl-35165123

Assuntos

COVID-19; Transplante de Rim; Anticorpos Antivirais; COVID-19/prevenção & controle; Vacinas contra COVID-19; Humanos; SARS-CoV-2; Transplantados; Vacinação

Palavras-chave

COVID-19; COVID-19 vaccines; SARS-CoV-2; T lymphocytes; intradermal vaccination; kidney transplant recipients; third dose

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Rim / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Rim / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article